Market Research Report
Blood Screening and Typing: Global Markets
|Published by||BCC Research||Product code||816258|
|Published||Content info||168 Pages
Delivery time: 1-2 business days
|Blood Screening and Typing: Global Markets|
|Published: March 27, 2019||Content info: 168 Pages||
The global market for blood screening and typing should grow from $7.7 billion in 2018 to reach $9.9 billion by 2023 at a compound annual growth rate (CAGR) of 5.0% for the period of 2018-2023.
Microbiology as a segment of blood screening and typing market should grow from $2.5 billion in 2018 to reach $3.3 billion by 2023 at a CAGR of 5.1% for the period of 2018-2023.
Nucleic acid amplification as a segment of blood screening and typing market should grow from $1.4 billion in 2018 to reach $1.9 billion by 2023 at a CAGR of 5.6% for the period of 2018-2023.
This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market. Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.
By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.
By end-user the market is segmented into hospitals, standalone blood banks and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.